|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
FY2013
12 months to Sep 30, 2013
|
|
|---|---|---|---|
| Cash flows from operating activities | |||
| Net loss | |||
| Adjustments to reconcile net loss to cash used in operating activities | |||
| Depreciation and amortization | |||
| Asset Impairment Charges | |||
| Deferred income taxes | |||
| Increase (Decrease) in Deferred Income Taxes | |||
| Change in fair value of conversion option liability | |||
| Share-based compensation | |||
| Issuance of warrants for referral fees | |||
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Accounts receivable | |||
| Prepaid expenses and other assets | |||
| Deferred revenue, including long-term portion | |||
| Accounts payable | |||
| Accrued expenses and other | |||
| Net cash provided by (used in) operating activities | |||
| Cash flows from investing activities | |||
| Decrease (increase) in restricted cash | |||
| Purchases of property and equipment, including software development costs | |||
| Acquisitions of businesses, net of cash acquired | |||
| Net cash used in investing activities | |||
| Cash flows from financing activities | |||
| Partner’s investment in joint venture | |||
| Principal payments on loan payable | |||
| Payments on capital leases | |||
| Proceeds from convertible debt and notes payable | |||
| Proceeds from debt issuances | |||
| Repayments of debt | |||
| Proceeds from debentures | |||
| Proceeds from issuance of warrants | |||
| Proceeds from exercise of stock options and warrants | |||
| Proceeds from exercise of options and warrants | |||
| Payment to Acquire Non-controlling Interest, Equity | |||
| Deferred financing costs | |||
| Proceeds from issuance of common stock in IPO and follow-on offering, net of underwriting discounts and commissions and other offering costs | |||
| Net repurchase of common shares | |||
| Other financing activities | |||
| Net cash provided by (used in) financing activities | |||
| Effect of changes in foreign exchange rates on cash and cash equivalents | |||
| Net increase (decrease) in cash and cash equivalents | |||
| Cash and cash equivalents | |||
| Beginning of period | |||
| End of period | |||
| Supplemental cash flow data: | |||
| Cash paid for interest | |||
| Property and Equipment Balances, Accounts Payable and Accrued Expenses | |||
| Issuance of common shares in connection with option exercises for which the Company has not yet received the cash | |||
| Non-cash investing and financing activities: | |||
| Accretion of redeemable securities | |||
| Redeemable Preferred Stock | |||
| Redeemable Non-Controlling Interest | |||
| Assets acquired under capital lease | |||
| Accrued offering costs | |||
| Reclassification of convertible preferred stock warrant liability to additional paid-in capital upon IPO | |||
| Conversion of convertible notes into common stock upon IPO | |||
| Conversion of Submittal Exchange Holdings Class A preferred units into common stock upon IPO | |||
| Reclassification of redeemable common stock upon IPO | |||
| Fair value of warrants reclassified to equity upon IPO | |||
| Warrants issued for mortgage renewal |
Loading...